- Founded
- 2014-01-01 in United States
Analome is a privately held US-based bioinformatics services firm founded in 2014, offering custom genomics, data science, and strategic consulting to biotechnology clients worldwide. The company’s team, averaging over 25 years of commercial biotech experience, delivers tailored solutions from early-stage R&D through regulatory submission, differentiating itself from larger one-size-fits-all providers. Analome operates with a flat organizational structure and a small headcount, enabling direct communication with senior scientists and leadership. The company serves early-stage startups to established pharmaceutical companies, providing services including sequencing strategy design, bioinformatics pipeline optimization, genomic data analytics, and FDA/EMA submission support. Its engagement model emphasizes close collaboration with client management and scientific teams throughout the project lifecycle. Analome’s stated values—honesty, integrity, respect, high standards, and fast execution—are encapsulated in its 'Analome Way' approach. While headquartered in the United States, Analome’s exact location is not publicly disclosed, and it appears to be self-funded with no disclosed funding rounds or notable partnerships.
Detailed Review
History and Founding
Analome was founded in 2014 in the United States by Jacques Borno, who serves as Founder & CEO. The company was established to address the need for truly customized bioinformatics and genomics services, contrasting with the standardized offerings of larger contract research organizations. The team's deep industry experience, averaging over 25 years per member from commercial biotech backgrounds, has been a cornerstone of the company's approach.
Business Model
Analome operates as a privately held, self-funded consulting and services firm. It does not disclose funding rounds or partnerships, indicating an organic growth model. The company's revenue comes from project-based engagements, ranging from small-scale genomic data analysis to comprehensive regulatory studies. Its flat organizational structure and small team enable cost efficiency and direct communication with clients' senior leadership.
Services and Capabilities
Analome offers a suite of service lines rather than branded products. These include custom genomics and bioinformatics solutions, bioinformatics pipeline optimization, genomic data science and analytics, regulatory science and submission support for FDA and EMA, project and product development management, scientific advisory and technical consulting, and information management for omics data. The company employs standard omics tools, cloud-based pipelines, and proprietary methodologies developed through years of client work.
Market Position and Competition
Analome positions itself as a flexible, client-centric alternative to larger vendors that offer pre-packaged solutions. Its target clients are biotechnology companies across the product pipeline, from early-stage R&D to regulatory submission. The company's small size and direct access to senior scientists are key competitive advantages. It serves a global customer base but operates from the United States. No major partnerships or M&A activity are publicly known.
Leadership
The two confirmed executives are Jacques Borno, CFP®, Founder & CEO, and David Kovalic, Ph.D., President. Borno oversees strategic direction and client relationships, while Kovalic leads scientific and project delivery teams. No other C-level positions are confirmed in available sources. The company's about page does not list individual leaders, but a 2018 profile on CIO Applications provides these names.
Regulatory and Industry Relevance
Analome's regulatory science services are particularly valued for supporting pre-submission meetings, 510(k) and PMA filings, and compliance with FDA and EMA guidelines for genomics-based diagnostics and therapeutics. The company's deep experience helps clients anticipate common pitfalls and meet both scientific and regulatory standards.
Key Products
Scientific advisory and technical consulting
Expert guidance on genomics strategies, experimental design, and technical challenges.
Custom genomics & bioinformatics solutions
Tailored services including sequencing strategy design, data generation oversight, and analysis.
Bioinformatics pipeline optimization
Improvement and customization of bioinformatics workflows for client-specific needs.
Genomic data science and analytics
Advanced analysis of genomic data to derive biological insights and support decision-making.
Regulatory science and submission support
Assistance with FDA and EMA pre-submission meetings, 510(k) and PMA filings, and compliance for genomics-based products.
Project and product development management
End-to-end management of genomic and bioinformatics projects from planning through execution.
Information management for omics data
Organization, storage, and retrieval solutions for large-scale omics datasets.